Literature DB >> 16767959

Imaging of neck metastases.

Shu-Hang Ng1, Sheung-Fat Ko, Cheng-Hong Toh, Yao-Liang Chen.   

Abstract

Awareness of the presence of cervical node metastasis is important in treatment planning and in prognostic prediction for patients with head and neck cancer. Currently, MRI and CT are commonly used to evaluate the primary tumor and the neck status. They characterize the cervical lymph nodes dependent on morphological criteria. However, metastases may be missed in some morphologically normal nodes. Conversely, it is difficult to discriminate reactive hyperplasia from metastasis in some enlarged nodes. Doppler ultrasound with fine-needle aspiration can overcome some of these limitations, but it is dependent on the sonographer's skill level and may be impractical in some cases due to too many questionable nodes. Positron emission tomography (PET) is a functional imaging that can detect metastasis lesions by pinpointing regions of high metabolism. It is better suited for assessing metastases to lymph nodes that appear morphologically normal. The main drawback of PET is its poor anatomical resolution. Side-by-side visual correlation of PET and CT/MRI can help determine the anatomical location of abnormal PET uptake and eliminate some false-positive PET findings caused by spatial errors. Fused PET/CT is considered to be the most accurate imaging modality for detecting nodal metastases, because it simultaneously provides prompt and accurate coregistration of functional and anatomical images. However, it is expensive, less-often available, and still constrained by technical resolution limits for tiny nodal metastases. Diffusion-weighted MRI, dynamic contrast-enhanced MRI, and nanoparticle-enhanced MRI are novel imaging technologies that have been exploited to enhance the detection of metastatic nodes. The initial results have been promising; however, micrometastases can still not be detected, and the extra costs and logistical burdens associated with these techniques prevent them from gaining wider acceptance. To date, neck dissection with detailed pathological examination is the gold standard. There is always a need for further refinement of the imaging techniques that can provide accurate information that approaches this gold standard.

Entities:  

Mesh:

Year:  2006        PMID: 16767959

Source DB:  PubMed          Journal:  Chang Gung Med J        ISSN: 2072-0939


  6 in total

Review 1.  Prognostic biological features in neck dissection specimens.

Authors:  Julia A Woolgar; Asterios Triantafyllou; James S Lewis; Jennifer Hunt; Michelle D Williams; Robert P Takes; Lester D R Thompson; Pieter J Slootweg; Kenneth O Devaney; Alfio Ferlito
Journal:  Eur Arch Otorhinolaryngol       Date:  2012-09-15       Impact factor: 2.503

2.  Comprehensive imaging of residual/ recurrent nasopharyngeal carcinoma using whole-body MRI at 3 T compared with FDG-PET-CT.

Authors:  Shu-Hang Ng; Sheng-Chieh Chan; Tzu-Chen Yen; Chun-Ta Liao; Joseph Tung-Chieh Chang; Sheung-Fat Ko; Hung-Ming Wang; Chin-Yu Lin; Kai-Ping Chang; Yu-Chun Lin
Journal:  Eur Radiol       Date:  2010-09       Impact factor: 5.315

Review 3.  Prognostic Stratification of Patients With Advanced Oral Cavity Squamous Cell Carcinoma.

Authors:  Dante De Paz; Huang-Kai Kao; Yenlin Huang; Kai-Ping Chang
Journal:  Curr Oncol Rep       Date:  2017-08-10       Impact factor: 5.075

4.  PET/CT and 3-T whole-body MRI in the detection of malignancy in treated oropharyngeal and hypopharyngeal carcinoma.

Authors:  Shu-Hang Ng; Sheng-Chieh Chan; Tzu-Chen Yen; Chun-Ta Liao; Chin-Yu Lin; Joseph Tung-Chieh Chang; Sheung-Fat Ko; Hung-Ming Wang; Kai-Ping Chang; Kang-Hsing Fan
Journal:  Eur J Nucl Med Mol Imaging       Date:  2011-02-15       Impact factor: 9.236

5.  Use of high frequency ultrasound to monitor cervical lymph node alterations in mice.

Authors:  Elyse L Walk; Sarah McLaughlin; James Coad; Scott A Weed
Journal:  PLoS One       Date:  2014-06-23       Impact factor: 3.240

6.  Patterns of lymph node recurrence after radical surgery impacting on survival of patients with pT1-3N0M0 thoracic esophageal squamous cell carcinoma.

Authors:  Xiao-Li Chen; Tian-Wu Chen; Zhi-Jia Fang; Xiao-Ming Zhang; Zhen-Lin Li; Hang Li; Hong-Jie Tang; Li Zhou; Dan Wang; Zishu Zhang
Journal:  J Korean Med Sci       Date:  2014-01-28       Impact factor: 2.153

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.